Abdominal Obesity as the Anchor Criterion
Waist circumference flags visceral fat, the metabolic syndrome starting point.
- ≥102 cm: Threshold used (placeholder generic cutoff)
- Anthropometric: Marker type (simple tape measurement)
- Visceral fat: Underlying driver (placeholder mechanism note)
- High: Population relevance (placeholder prevalence note)
Why waist circumference matters
Placeholder: visceral adiposity drives downstream metabolic dysfunction.
Hypertension as a Cluster Component
Elevated blood pressure adds cardiovascular strain to the criteria set.
- ≥130/85: Threshold used (placeholder cutoff mmHg)
- Hemodynamic: Marker type (placeholder measurement note)
- Vascular resistance: Underlying driver (placeholder mechanism note)
- Strong: Comorbidity link (placeholder association note)
Why blood pressure is included
Placeholder: pressure elevation tracks with insulin resistance pathways.
Glycemic Dysregulation Signal
Fasting glucose elevation marks emerging insulin resistance.
- ≥100 mg/dL: Threshold used (placeholder cutoff)
- Biochemical: Marker type (placeholder blood test)
- Insulin resistance: Underlying driver (placeholder mechanism note)
- Diabetes: Progression risk (placeholder outcome note)
Why glucose is a core criterion
Placeholder: fasting glucose bridges metabolic syndrome and diabetes risk.
Atherogenic Dyslipidemia Pair
High triglycerides paired with low HDL define the lipid criteria.
- ≥150 mg/dL: TG threshold (placeholder cutoff)
- <40 mg/dL: HDL threshold (placeholder cutoff)
- Lipid panel: Marker type (placeholder blood test)
- Strong: Atherogenic link (placeholder association note)
Why two lipid criteria count separately
Placeholder: triglycerides and HDL move independently yet compound risk.
Meeting Three of Five Criteria
Metabolic syndrome is diagnosed once three or more criteria are met.
- ≥3 of 5: Diagnostic rule (placeholder cutoff rule)
- 5: Components total (placeholder count)
- Compounding: Risk multiplier (placeholder note)
- Lifestyle + monitoring: Clinical action (placeholder note)
Why the cluster threshold matters
Placeholder: combined criteria predict risk better than any single marker.
Placeholder key insight: clustered components multiply cardiometabolic risk.